Deciduous Therapeutics ^Clinics

Developer of novel therapeutics designed for the treatment of age-related diseases. The company's novel molecules can activate a critical endogenous immune surveillance mechanism to selectively remove senescent cells, enabling healthcare providers to treat several classes of age-related Therapeutics Company Profile 2025: Valuation, ?